183 related articles for article (PubMed ID: 20383938)
1. Development and characterization of in situ gel system for nasal insulin delivery.
Agrawal AK; Gupta PN; Khanna A; Sharma RK; Chandrawanshi HK; Gupta N; Patil UK; Yadav SK
Pharmazie; 2010 Mar; 65(3):188-93. PubMed ID: 20383938
[TBL] [Abstract][Full Text] [Related]
2. A thermosensitive hydrogel based on quaternized chitosan and poly(ethylene glycol) for nasal drug delivery system.
Wu J; Wei W; Wang LY; Su ZG; Ma GH
Biomaterials; 2007 Apr; 28(13):2220-32. PubMed ID: 17291582
[TBL] [Abstract][Full Text] [Related]
3. Effect of binder additives on terbutaline hydrogels of alpha-PVA/NaCl/H(2)O system in drug delivery: I. Effect of gelatin and soluble starch.
Shaheen SM; Takezoe K; Yamaura K
Biomed Mater Eng; 2004; 14(4):371-82. PubMed ID: 15472386
[TBL] [Abstract][Full Text] [Related]
4. Cyclodextrin complexed insulin encapsulated hydrogel microparticles: An oral delivery system for insulin.
Sajeesh S; Bouchemal K; Marsaud V; Vauthier C; Sharma CP
J Control Release; 2010 Nov; 147(3):377-84. PubMed ID: 20727924
[TBL] [Abstract][Full Text] [Related]
5. Characterization of thermosensitive chitosan-based hydrogels by rheology and electron paramagnetic resonance spectroscopy.
Kempe S; Metz H; Bastrop M; Hvilsom A; Contri RV; Mäder K
Eur J Pharm Biopharm; 2008 Jan; 68(1):26-33. PubMed ID: 17870449
[TBL] [Abstract][Full Text] [Related]
6. Design and evaluation of biodegradable, biosensitive in situ gelling system for pulsatile delivery of insulin.
Kashyap N; Viswanad B; Sharma G; Bhardwaj V; Ramarao P; Ravi Kumar MN
Biomaterials; 2007 Apr; 28(11):2051-60. PubMed ID: 17240443
[TBL] [Abstract][Full Text] [Related]
7. A thermosensitive chitosan/poly(vinyl alcohol) hydrogel containing hydroxyapatite for protein delivery.
Tang Y; Du Y; Li Y; Wang X; Hu X
J Biomed Mater Res A; 2009 Dec; 91(4):953-63. PubMed ID: 19097146
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of chitosan-polyvinyl alcohol blend hydrogels for the controlled release of nano-insulin.
Zu Y; Zhang Y; Zhao X; Shan C; Zu S; Wang K; Li Y; Ge Y
Int J Biol Macromol; 2012 Jan; 50(1):82-7. PubMed ID: 22020189
[TBL] [Abstract][Full Text] [Related]
9. Nasal insulin delivery in the chitosan solution: in vitro and in vivo studies.
Yu S; Zhao Y; Wu F; Zhang X; Lü W; Zhang H; Zhang Q
Int J Pharm; 2004 Aug; 281(1-2):11-23. PubMed ID: 15288339
[TBL] [Abstract][Full Text] [Related]
10. Gel characterisation and in vivo evaluation of minocycline-loaded wound dressing with enhanced wound healing using polyvinyl alcohol and chitosan.
Sung JH; Hwang MR; Kim JO; Lee JH; Kim YI; Kim JH; Chang SW; Jin SG; Kim JA; Lyoo WS; Han SS; Ku SK; Yong CS; Choi HG
Int J Pharm; 2010 Jun; 392(1-2):232-40. PubMed ID: 20230884
[TBL] [Abstract][Full Text] [Related]
11. Effective insulin delivery using starch nanoparticles as a potential trans-nasal mucoadhesive carrier.
Jain AK; Khar RK; Ahmed FJ; Diwan PV
Eur J Pharm Biopharm; 2008 Jun; 69(2):426-35. PubMed ID: 18295464
[TBL] [Abstract][Full Text] [Related]
12. Controlled release of insulin from pH/temperature-sensitive injectable pentablock copolymer hydrogel.
Huynh DP; Im GJ; Chae SY; Lee KC; Lee DS
J Control Release; 2009 Jul; 137(1):20-4. PubMed ID: 19285530
[TBL] [Abstract][Full Text] [Related]
13. Development and in-vivo evaluation of insulin-loaded chitosan phthalate microspheres for oral delivery.
Ubaidulla U; Khar RK; Ahmed FJ; Panda AK
J Pharm Pharmacol; 2007 Oct; 59(10):1345-51. PubMed ID: 17910808
[TBL] [Abstract][Full Text] [Related]
14. Potential use of gamma-cyclodextrin polypseudorotaxane hydrogels as an injectable sustained release system for insulin.
Abu Hashim II; Higashi T; Anno T; Motoyama K; Abd-ElGawad AE; El-Shabouri MH; Borg TM; Arima H
Int J Pharm; 2010 Jun; 392(1-2):83-91. PubMed ID: 20298768
[TBL] [Abstract][Full Text] [Related]
15. Aminated gelatin microspheres as a nasal delivery system for peptide drugs: evaluation of in vitro release and in vivo insulin absorption in rats.
Wang J; Tabata Y; Morimoto K
J Control Release; 2006 Jun; 113(1):31-7. PubMed ID: 16707188
[TBL] [Abstract][Full Text] [Related]
16. Formulation and characterization of an oily-based system for oral delivery of insulin.
Elsayed A; Remawi MA; Qinna N; Farouk A; Badwan A
Eur J Pharm Biopharm; 2009 Oct; 73(2):269-79. PubMed ID: 19508890
[TBL] [Abstract][Full Text] [Related]
17. On the design of in situ forming biodegradable parenteral depot systems based on insulin loaded dialkylaminoalkyl-amine-poly(vinyl alcohol)-g-poly(lactide-co-glycolide) nanoparticles.
Packhaeuser CB; Kissel T
J Control Release; 2007 Nov; 123(2):131-40. PubMed ID: 17854938
[TBL] [Abstract][Full Text] [Related]
18. Biodegradable in situ gel-forming controlled drug delivery system based on thermosensitive PCL-PEG-PCL hydrogel. Part 2: sol-gel-sol transition and drug delivery behavior.
Gong C; Shi S; Wu L; Gou M; Yin Q; Guo Q; Dong P; Zhang F; Luo F; Zhao X; Wei Y; Qian Z
Acta Biomater; 2009 Nov; 5(9):3358-70. PubMed ID: 19470411
[TBL] [Abstract][Full Text] [Related]
19. Controlled release of insulin from self-assembling nanofiber hydrogel, PuraMatrix™: application for the subcutaneous injection in rats.
Nishimura A; Hayakawa T; Yamamoto Y; Hamori M; Tabata K; Seto K; Shibata N
Eur J Pharm Sci; 2012 Jan; 45(1-2):1-7. PubMed ID: 22064453
[TBL] [Abstract][Full Text] [Related]
20. Characterization of ph- and thermosensitive hydrogel as a vehicle for controlled protein delivery.
Shi W; Ji Y; Zhang X; Shu S; Wu Z
J Pharm Sci; 2011 Mar; 100(3):886-95. PubMed ID: 20862775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
